Quantcast
Home > Quotes > PEN
x

Penumbra, Inc. Common Stock (PEN) Quote & Summary Data

PEN 
$136.97
*  
3.87
2.75%
Get PEN Alerts
*Delayed - data as of Oct. 19, 2018  -  Find a broker to begin trading PEN now
Exchange:NYSE
Industry: Health Care
Community Rating:
View:    PEN Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

1 Year Target
152.5
Today's High / Low
$ 142.62 / $ 136.01
Share Volume
203,742
90 Day Avg. Daily Volume
376,684
Previous Close
$ 140.84
52 Week High / Low
$ 167.35 / $ 82.55
Market Cap
4,708,940,117
P/E Ratio
175.6
Forward P/E (1y)
507.30
Earnings Per Share (EPS)
$ 0.78
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.47

Intraday Chart

Shares Traded

Share Volume:
203,742
90 Day Avg. Daily Volume:
376,684

P/E Ratio

P/E Ratio:
175.6
Forward P/E (1y):
507.30
Earnings Per Share (EPS):
$ 0.78

Trading Range

The current last sale of $136.97 is 65.92% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 142.62 $ 167.35
 Low: $ 136.01 $ 82.55

Company Description (as filed with the SEC)

References herein to "we," "us," "our," "Company," and "Penumbra," refer to Penumbra, Inc. and its consolidated subsidiaries unless the context specifically states otherwise. Penumbra is a global healthcare company focused on innovative therapies. We design, develop, manufacture and market medical devices and have a broad portfolio of products that addresses challenging medical conditions and significant clinical needs. Our team focuses on developing, manufacturing and marketing products for use by specialist physicians, including interventional neuroradiologists, neurosurgeons, interventional neurologists, interventional radiologists, interventional cardiologists and vascular surgeons. We design our products to provide these specialist physicians with a means to drive improved clinical outcomes.  ... More ...  


Risk Grade

Where does PEN fit in the risk graph?


Risk Grade Scale

Consensus Recommendation

Analyst Info